Comerica Securities,Inc. Horizon Therapeutics Public LTD CO Transaction History

Comerica Securities,Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$62.39 - $113.8 $67,194 - $122,562	1,077 New	1,077 $122,000
Q2 2022 Jul 19, 2022	SELL	$79.4 - $116.36 $176,188 - $258,202	-2,219 Closed	0 $0
Q1 2022 Apr 28, 2022	SELL	$86.42 - $109.81 $4,321 - $5,490	-50 Reduced 2.2%	2,219 $233,000
Q4 2021 Feb 10, 2022	BUY	$98.56 - $119.91 $8,279 - $10,072	84 Added 3.84%	2,269 $245,000
Q3 2021 Nov 10, 2021	BUY	$91.91 - $110.37 $200,823 - $241,158	2,185 New	2,185 $239,000
Q2 2021 Aug 11, 2021	SELL	$86.24 - $95.92 $389,287 - $432,982	-4,514 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$71.83 - $95.48 $66,299 - $88,128	923 Added 25.7%	4,514 $415,000
Q4 2020 Feb 09, 2021	BUY	$67.0 - $84.39 $41,004 - $51,646	612 Added 20.54%	3,591 $263,000
Q3 2020 Nov 04, 2020	BUY	$55.23 - $79.93 $164,530 - $238,111	2,979 New	2,979 $231,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Comerica Securities,Inc., based on Form 13F filings with the SEC.

Stay updated on Comerica Securities,Inc. with notifications on news.